Correction: Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets
AAPS J
.
2023 Jun 8;25(4):58.
doi: 10.1208/s12248-023-00827-0.
Authors
Yasuhiro Tsume
1
,
Lee Ashworth
2
,
Marival Bermejo
3
,
Joan Cheng
4
,
Vincent Cicale
5
,
Jennifer Dressman
6
7
,
Masahiro Fushimi
8
,
Isabel Gonzalez-Alvarez
3
,
Yiwang Guo
4
,
Corinne Jankovsky
9
,
Xujin Lu
5
,
Kazuki Matsui
8
,
Sanjaykumar Patel
10
,
Natalie Sanderson
2
,
Changquan Calvin Sun
4
,
Naveen K Thakral
11
,
Miki Yamane
8
,
Laurin Zöller
7
Affiliations
1
Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey, USA. yasuhiro.tsume@merck.com.
2
AstraZeneca, Macclesfield, UK.
3
Miguel Hernandez University, Alicante, Spain.
4
University of Minnesota, Minneapolis, Minneapolis, USA.
5
Bristol-Myers Squibb Company, New Brunswick, New Jersey, USA.
6
Fraunhofer Institute for Translational Medicine Pharmacology, Frankfurt, Germany.
7
Goethe Universität, Frankfurt, Germany.
8
Sawai Pharmaceutical Co. Ltd., Osaka, Japan.
9
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
10
Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey, USA.
11
Schrodinger Inc., New York, New York, USA.
PMID:
37291273
DOI:
10.1208/s12248-023-00827-0
No abstract available
Publication types
Published Erratum